TREACE MEDICAL CONCEPTS, INC. TMCI

Rank #2281 · Nasdaq · $0.3B market cap

Audited by GRANT THORNTON LLP, no going-concern flag in the latest filing.

Score

26.2

P/E

-5.8

P/B

4.75

ROE

-81.8%

Op. Margin

-27.5%

Debt Ratio

172%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★☆☆☆☆

Weak

P/E -5.8x, P/B 4.75x. Ranks in the top 76% of the universe.

Profitability ★☆☆☆☆

Poor

ROE -81.8%. Ranks in the top 88% of the universe.

Safety ★★☆☆☆

Average

Debt ratio 172%. Ranks in the top 57% of the universe.

Growth ★★★★☆

Excellent

Revenue growth of 31.9% year over year. Ranks in the top 11% of the universe.

Growth is the relative strength · Valuation is the relative weakness (relative to this universe).

FY	Revenue	Op. Income	Net Income	Equity	Op. Margin%	Debt%
2021	$0.0B	$-0.0B	$-0.0B	$0.0B	-9.0	690
2022	$0.1B	$0.0B	$-0.0B	$0.0B	1.5	1511
2023	$0.1B	$-0.0B	$-0.0B	$0.0B	-17.5	12693
2024	$0.1B	$-0.0B	$-0.0B	$0.1B	-24.6	122
2025	$0.2B	$-0.1B	$-0.0B	$0.1B	-27.5	172